Skip to main content

Physician Resource Center

Featured Content View More

Roswell Park Care Network Collaboration in Action Video

Roswell Park Care Network Collaboration in Action

The Roswell Park Care Network promises to bring the same level of care to its affiliate locations as patients receive at the main hospital in downtown Buffalo

Roswell Park Faculty to Present at National Comprehensive Cancer Network 2026 Annual Conference News

Roswell Park Faculty to Present at National Comprehensive Cancer Network 2026 Annual Conference

Clinical researchers from Roswell Park Comprehensive Cancer Center are among the experts invited to share insights and clinical best practices at the National Comprehensive Cancer Network (NCCN) 2026 Annual Conference March 27-29 in Orlando, Florida.

New Phase I/II Trial Using Multimodal PDT for Advanced, Recurrent Colorectal Cancer Video

New Phase I/II Trial Using Multimodal PDT for Advanced, Recurrent Colorectal Cancer

Long a pioneer in innovative treatments for colorectal cancer, Roswell Park Comprehensive Cancer Center is recruiting patients with locally advanced or recurring colorectal cancer for a new trial involving photodynamic therapy, a technology ...

Register Today for Roswell Park’s Upstate New York Hematology & Hematologic Oncology Conference News

Register Today for Roswell Park’s Upstate New York Hematology & Hematologic Oncology Conference

Register for the Upstate New York Hematology & Hematologic Oncology Conference: A Review of the 67th ASH Annual meeting, taking place on April 25-26 in Buffalo, NY.

Live Procedure - Histotripsy: A Noninvasive Ablation Procedure for Liver Cancer Video

Live Procedure - Histotripsy: A Noninvasive Ablation Procedure for Liver Cancer

Watch as Roswell Park interventional radiologist Dr. Omar Hasan explains and demonstrates a new noninvasive type of ablation therapy offering new hope for patients with primary liver cancer or liver metastases.

Can Induction Improve Survival in High-Risk, Locally Advanced Cervical Cancer? News

Can Induction Improve Survival in High-Risk, Locally Advanced Cervical Cancer?

Rates of overall and progression-free survival for locally advanced cervical cancer have risen significantly since 2024, when the FDA approved the use of pembrolizumab (brand name Keytruda) with chemoradiation for stage 3-4A disease.

This site is intended for healthcare professionals

RPMD App
Access wherever you go

Click your preferred app store below to download our free mobile app — exclusively for physicians and physician offices — for direct access to a complete, up-to-date directory of Roswell Park physicians wherever you go. Email or call to refer a patient or ask a question with a click of a button.

Upcoming Physician & Research Events

Buffalo RNA Symposium 2025

June 11, 2025 | Buffalo, NY

5th Translational Genomics & Epigenomics Symposium

September 18-19, 2025 | Buffalo, NY


Powered by BroadcastMedBROADCASTMED
BroadcastMed Privacy Policy